162 related articles for article (PubMed ID: 11594576)
1. Treatment of cutaneous T cell lymphoma stage II with interferon-alpha-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
Ann N Y Acad Sci; 2001 Sep; 941():210-3. PubMed ID: 11594576
[No Abstract] [Full Text] [Related]
2. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract][Full Text] [Related]
3. Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma.
Zachariae H; Thestrup-Pedersen K
J Invest Dermatol; 1990 Dec; 95(6 Suppl):206S-208S. PubMed ID: 2258637
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients with cutaneous T cell lymphoma after treatment with extracorporeal photochemotherapy: a retrospective single-center analysis.
Wollina U; Liebold K; Kaatz M; Looks A; Stuhlert A; Lange D
Ann N Y Acad Sci; 2001 Sep; 941():217-9. PubMed ID: 11594578
[No Abstract] [Full Text] [Related]
5. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
[No Abstract] [Full Text] [Related]
6. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W
Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550
[TBL] [Abstract][Full Text] [Related]
7. Partial regrowth of scalp hair in a patient treated with extracorporeal photochemotherapy and interferon alpha 2a.
Wollina U
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):261-2. PubMed ID: 9883441
[No Abstract] [Full Text] [Related]
8. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
Stadler R; Otte HG
Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
[TBL] [Abstract][Full Text] [Related]
9. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
[TBL] [Abstract][Full Text] [Related]
10. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatment for cutaneous lymphomas.
Mielke V; Staib G; Sterry W
Recent Results Cancer Res; 1995; 139():403-8. PubMed ID: 7597307
[TBL] [Abstract][Full Text] [Related]
12. Role of extracorporeal photochemotherapy alone and in combination with interferon alfa in the treatment of cutaneous T-cell lymphoma.
Fimiani M; Rubegni P; De Aloe G; Andreassi L
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):502-3. PubMed ID: 10459134
[No Abstract] [Full Text] [Related]
13. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
Aviles A; Neri N; Fernandez-Diez J; Silva L; Nambo MJ
Hematology; 2015 Oct; 20(9):538-42. PubMed ID: 25592781
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photochemotherapy in long-term treatment of early stage cutaneous T-cell lymphoma.
Rubegni P; De Aloe G; Fimiani M
Br J Dermatol; 2000 Oct; 143(4):894-6. PubMed ID: 11069483
[No Abstract] [Full Text] [Related]
15. Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma.
Zackheim HS
J Am Acad Dermatol; 2000 Jun; 42(6):1087-8. PubMed ID: 10827420
[No Abstract] [Full Text] [Related]
16. Alternating recombinant and natural alpha-interferon helps to prevent clinical resistance to interferon in cutaneous T-cell lymphoma treatment.
Altomare G; Capella GL; Frigerio E
Acta Derm Venereol; 1998 Mar; 78(2):159. PubMed ID: 9534907
[No Abstract] [Full Text] [Related]
17. U.K. national audit of extracorporeal photopheresis in cutaneous T-cell lymphoma.
Sanyal S; Child F; Alfred A; Callaghan T; Alband N; Whittaker S; Cowan R; Parry E; Robinson S; Dunnill MGS; Wain M; Morris S; Malladi R; Tahir S; Howles A; Arumainathan A; Azurdia R; Grant-Casey J; Matin RN; Gilson D; Howell C; El-Gheriani K; Taylor P; Scarisbrick J
Br J Dermatol; 2018 Feb; 178(2):569-570. PubMed ID: 28782100
[No Abstract] [Full Text] [Related]
18. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma.
Dippel E; Schrag H; Goerdt S; Orfanos CE
Lancet; 1997 Jul; 350(9070):32-3. PubMed ID: 9217723
[No Abstract] [Full Text] [Related]
19. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
[TBL] [Abstract][Full Text] [Related]
20. Onset of non-AIDS Kaposi sarcoma during therapy with interferon alfa-2a in an 82-year-old man with concomitant cutaneous T-cell lymphoma.
Giuliani M; Mastroianni A; Di Carlo A; Donati P; Miceli M; Monini P; Rezza G
Arch Dermatol; 2002 Apr; 138(4):535-7. PubMed ID: 11939825
[No Abstract] [Full Text] [Related]
[Next] [New Search]